Growth of molecular imaging industry expected to continue

05/30/2013 | MolecularImaging.net

The molecular imaging industry is poised to continue growing, driven by emerging markets and growth of hybrid modalities such as PET/CT, according to a report from Espicom Business Intelligence. The report also noted a trend toward increased use of PET as an alternative to SPECT and the emergence of scalable and cost-effective cyclotrons. Cardiology, oncology and neurology -- dementia in particular -- are all robust growth areas.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ